Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Announcing a new article publication for BIO Integration journal. Alzheimer's disease (AD) is a neurodegenerative disorder ...

Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...

The country’s first end-to-end workflow unites IRB Barcelona’s core facilities to support spatial omics for researchers, ...

A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...

Researchers from the National University of Singapore (NUS) have developed CellScope, a high-performance single-cell analysis ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' spatial context.

Stellaromics today launched Pyxatm, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...

Researchers mapped nearly 91,000 healthy bone marrow cells from donors aged two to 32, creating the first pediatric atlas.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...